TY - JOUR
T1 - Scope of worldwide hepatitis C problem
AU - Brown, Robert S.
AU - Gaglio, Paul J.
PY - 2003/11
Y1 - 2003/11
N2 - Key Points: 1. Hepatitis C is a global health problem affecting over 170 million people worldwide. 2. There is wide geographic variation in both prevalence and genotype distribution of hepatitis C virus on a global level. 3. Most hepatitis C virus is spread parenterally, either through intravenous drug use or, in lesser-developed countries, through blood contamination during medical procedures. 4. Hepatitis C is a leading cause of end-stage liver disease and hepatocellular carcinoma. 5. Despite a declining incidence of new infections, the burden of disease, both in terms of mortality and in terms of cost, is expected to increase over the next decade.
AB - Key Points: 1. Hepatitis C is a global health problem affecting over 170 million people worldwide. 2. There is wide geographic variation in both prevalence and genotype distribution of hepatitis C virus on a global level. 3. Most hepatitis C virus is spread parenterally, either through intravenous drug use or, in lesser-developed countries, through blood contamination during medical procedures. 4. Hepatitis C is a leading cause of end-stage liver disease and hepatocellular carcinoma. 5. Despite a declining incidence of new infections, the burden of disease, both in terms of mortality and in terms of cost, is expected to increase over the next decade.
UR - http://www.scopus.com/inward/record.url?scp=0242456086&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0242456086&partnerID=8YFLogxK
U2 - 10.1053/jlts.2003.50244
DO - 10.1053/jlts.2003.50244
M3 - Article
C2 - 14586889
AN - SCOPUS:0242456086
SN - 1527-6465
VL - 9
SP - S10-S13
JO - Liver Transplantation
JF - Liver Transplantation
IS - 11
ER -
